Elevation of urinary liver-type fatty acid binding protein after cardiac catheterization related to cardiovascular events

References

• ShahBNGreavesKThe Cardiorenal Syndrome: A reviewInt J Nephrol2010201192019521253529
   PubMedGoogle Scholar
• SarnakMJLeveyASSchoolwerthACKidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and PreventionCirculation2003108172154216914581387
   PubMed Web of Science ®Google Scholar
• DiercksGFvan BovenAJHillegeHLMicroalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) studyEur Heart J200021231922192711071797
   PubMed Web of Science ®Google Scholar
• DeckertTFeldt-RasmussenBBorch-JohnsenKJensenTKofoed-EnevoldsenAAlbuminuria reflects widespread vascular damage. The Steno hypothesisDiabetologia19893242192262668076
   PubMed Web of Science ®Google Scholar
• StehouwerCDHenryRMDekkerJMNijpelsGHeineRJBouterLMMicroalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: Further evidence for a link between microalbuminuria and endothelial dysfunction – the Hoorn StudyKidney Int Suppl200492S42S4415485416
   PubMed Web of Science ®Google Scholar
• SendeskiMMPerssonABLiuZZIodinated contrast media cause endothelial damage leading to vasoconstriction of human and rat vasa rectaAm J Physiol Renal Physiol201230312F1592F159823077094
   PubMed Web of Science ®Google Scholar
• SeeligerESendeskiMRihalCSPerssonPBContrast-induced kidney injury: Mechanisms, risk factors, and preventionEur Heart J201233162007201522267241
   PubMed Web of Science ®Google Scholar
• FrankeRPJungFPathophysiology of the contrast media-induced nephropathy (CIN) in patients undergoing coronary interventionsClin Hemorheol Microcirc2013531–214315322951623
   PubMed Web of Science ®Google Scholar
• RoncoCHaapioMHouseAAAnavekarNBellomoRCardiorenal syndromeJ Am Coll Cardiol200852191527153919007588
   PubMed Web of Science ®Google Scholar
• VeerkampJHPeetersRAMaatmanRGStructural and functional features of different types of cytoplasmic fatty acid-binding proteinsBiochim Biophys Acta1991108111241991151
   PubMed Web of Science ®Google Scholar
• VeerkampJHvan KuppeveltTHMaatmanRGPrinsenCFStructural and functional aspects of cytosolic fatty acid-binding proteinsProstaglandins Leukot Essent Fatty Acids19934968879068140117
   PubMed Web of Science ®Google Scholar
• Kamijo-IkemoriASugayaTIchikawaDUrinary liver type fatty acid binding protein in diabetic nephropathyClin Chim Acta201342410410823727660
   PubMed Web of Science ®Google Scholar
• YamamotoTNoiriEOnoYRenal L-type fatty acid – binding protein in acute ischemic injuryJ Am Soc Nephrol200718112894290217942962
   PubMed Web of Science ®Google Scholar
• Eynatten vonMBaumannMHeemannUUrinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetesEur J Clin Invest2010409510219912308
   PubMed Web of Science ®Google Scholar
• FukudaYMiuraSZhangBSignificance of urinary liver-fatty acid-binding protein in cardiac catheterization in patients with coronary artery diseaseIntern Med200948191731173719797828
   PubMed Web of Science ®Google Scholar
• ManabeKKamihataHMotohiroMSenooTYoshidaSIwasakaTUrinary liver-type fatty acid-binding protein level as a predictive bio-marker of contrast-induced acute kidney injuryEur J Clin Invest201242555756322070248
   PubMed Web of Science ®Google Scholar
• MatsumoriRShimadaKKiyanagiTClinical significance of the measurements of urinary liver-type fatty acid binding protein levels in patients with acute coronary syndromeJ Cardiol201260316817322658694
   PubMed Web of Science ®Google Scholar
• NakamuraTSugayaTNodeKUedaYKoideHUrinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathyAm J Kidney Dis200647343944416490622
   PubMed Web of Science ®Google Scholar
• KatoKSatoNYamamotoTIwasakiYKTanakaKMizunoKValuable markers for contrast-induced nephropathy in patients undergoing cardiac catheterizationCirc J20087291499150518724030
   PubMed Web of Science ®Google Scholar
• FujitaDTakahashiMDoiKResponse of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart diseaseHeart Vessels201530329630324554034
   PubMed Web of Science ®Google Scholar
• KamijoAKimuraKSugayaTUrinary fatty acid binding protein as a new clinical marker for the progression of chronic renal diseaseJ Lab Clin Med2004143233014749682
   PubMed Web of Science ®Google Scholar
• MatsuoSImaiEHorioMRevised equations for estimated GFR from serum creatinine in japanAm J Kidney Dis200953698299219339088
   PubMed Web of Science ®Google Scholar
• WongPCLiZGuoJZhangAPathophysiology of contrast-induced nephropathyInt J Cardiol2012158218619221784541
   PubMed Web of Science ®Google Scholar
• NangakuMChronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failureJ Am Soc Nephrol2006171172516291837
   PubMed Web of Science ®Google Scholar
• ArakiSHanedaMKoyaDPredictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathyDiabetes Care20133651248125323223350
   PubMed Web of Science ®Google Scholar
• NielsenSESugayaTHovindPBabaTParvingHHRossingPUrinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patientsDiabetes Care20103361320132420185732
   PubMed Web of Science ®Google Scholar
• Kamijo-IkemoriASugayaTYasudaTClinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patientsDiabetes Care201134369169621273494
   PubMed Web of Science ®Google Scholar
• MaedaYSuzukiAIshiiJLevel of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage g1 and g2Heart Vessels201530336236824626813
   PubMed Web of Science ®Google Scholar
• WeirMRMicroalbuminuria and cardiovascular diseaseClin J Am Soc Nephrol20072358159017699466
   PubMed Web of Science ®Google Scholar
• StehouwerCDSmuldersYMMicroalbuminuria and risk for cardiovascular disease: Analysis of potential mechanismsJ Am Soc Nephrol20061782106211116825333
   PubMed Web of Science ®Google Scholar
• KaptogeSDi AngelantonioELoweGC-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisLancet2010375970913214020031199
   PubMed Web of Science ®Google Scholar
• RidkerPMClinical application of C-reactive protein for cardiovascular disease detection and preventionCirculation2003107336336912551853
   PubMed Web of Science ®Google Scholar